Industry Analysis & Industry Trends
The Biotechnology industry investigates and capitalises on the commercial applications of biological manipulation. It is fast becoming a prominent part of the UK life sciences scene alongside pharmaceutical and medical technology firms. The convergence of these three technologies is making it increasingly difficult to identify the boundaries between them. The Biotechnology industry relies heavily on third-party financing, so the economic downturn posed significant funding challenges. Low business confidence made private financiers uncertain about investing in risky research and development (R&D) projects. This dampened growth, but could not contain it... purchase to read more
Industry Report - Industry Investment Chapter
The capital intensity of an industry is determined by comparing the human and capital equipment factors of production using wages and depreciation costs as proxies. Comparatively high depreciation costs indicate high investment in depreciable assets such as buildings and equipment, suggesting high capital intensity. Conversely, comparatively high wage costs indicate high labour intensity.
The industry relies on the application of knowledge by highly skilled staff in the research and development of biotechnology products... purchase to read more